36
Participants
Start Date
March 25, 2019
Primary Completion Date
July 2, 2019
Study Completion Date
October 22, 2019
CA-008
Drug: CA-008 4.2 mg reconstituted in saline
Ketorolac
30 mg IV at the onset of anesthesia
Acetaminophen IV
1 g at the onset of anesthesia
Fentanyl
100 mcg IV fentanyl administered at the onset of anesthesia and additional 50 mcg near the end of surgery
Bupivacaine Hydrochloride
0.25% 30 mL (75 mg) prior to surgery
Lidocaine HCl
1.5% 12 mL at the end of surgery
Celecoxib
200 mg PO bid each day postoperative
Acetaminophen Oral
1 g postoperative
Lidocaine Hydrochloride
2% 15 mL at the end of surgery
Exparel
Bupivacaine liposome injection suspension
Lotus Clinical Research, LLC, Pasadena
Lead Sponsor
Concentric Analgesics
INDUSTRY